These observations match to the report from Lipshultz et al. observing an increase in the percentage of patients with at least one elevated cTnT level with time of cancer treatment [19] and might be a hint that cTnT might be a suitable prognostic marker for anthracycline-induced cardiotoxicity. This evidence concerns the gene TNNT2 and cancer.